ZIMMER BIOMET HOLDINGS, INC. ZBH
NYSE · XNYS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Chart by TradingView
5/9
Piotroski F — financial health
3.96
Altman Z″ — distress risk · safe
27.0%
Dividend payout · safe
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $8.2B | $705.1M | — | $1.5B | $12.7B |
| 2024 | $7.7B | $903.8M | — | $1.3B | $12.5B |
| 2023 | $7.4B | $1.0B | — | $1.3B | $12.5B |
| 2022 | $6.9B | $231.4M | — | $1.2B | $12.0B |
| 2021 | $6.8B | $401.6M | — | $1.3B | $12.7B |
| 2020 | $6.1B | -$138.9M | — | $963.7M | $12.2B |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Yi Sang | Group President, Asia Pacific | 2026-05-29 | Sell | 4,200 | $82.64 |
| Yi Sang | Group President, Asia Pacific | 2026-05-29 | Sell | 800 | $82.66 |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.96 (safe)
- Working capital / assets 0.11
- Retained earnings / assets 0.503
- EBIT / assets 0.048
- Equity / liabilities 1.223
Source: SEC EDGAR filings · CIK 0001136869 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.